Pregnancy: a therapeutic dilemma

Ligia Brzezińska-Wcisło; Martyna Zbiciak-Nylec; Dominika Wcisło-Dziadecka; Natalia Salwowska

doi:10.5114/ada.2017.71108

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2017
vol. 34

Send email

Copy url:

abstract:

Review paper

Pregnancy: a therapeutic dilemma

Ligia Brzezińska-Wcisło

,

Martyna Zbiciak-Nylec

,

Dominika Wcisło-Dziadecka

,

Natalia Salwowska

Adv Dermatol Allergol 2017; XXXIV (5): 433–438

DOI: https://doi.org/10.5114/ada.2017.71108

Online publish date: 2017/10/31

View full text Get citation

Treatment during pregnancy is problematic. The Food and Drug Administration established drug categories to help in the treatment process. First-generation antihistamines are considered safe but they have sedative properties. Second-generation antihistamines cause less adverse reactions but besides cetirizine and loratadine they belong to category C. All retinoids should be avoided during pregnancy due to the risk of fetal malformations. Antimalarial drugs should be considered based on the clinical data. Sulfones can be considered as safe for use during pregnancy only with proper monitoring. Prednisone is administered in pregnancy. Other glucocorticosteroids have a different safety profile. Cyclosporine A treatment should be reserved as rescue therapy in severe stages of the disease. Treatment during pregnancy should be precise when it comes to pregnant woman and safe for the fetus.

keywords:

Pregnancy: a therapeutic dilemma

Ligia Brzezińska-Wcisło , Martyna Zbiciak-Nylec , Dominika Wcisło-Dziadecka , Natalia Salwowska

pregnancy, antihistamine, drug categories, retinoids, antimalarial drugs

Ligia Brzezińska-Wcisło

,

Martyna Zbiciak-Nylec

,

Dominika Wcisło-Dziadecka

,

Natalia Salwowska